BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 21724204)

  • 1. Transapical aortic valve implantation at 3 years.
    Walther T; Kempfert J; Rastan A; Borger MA; Linke A; Ender J; Schuler G; Mohr FW
    J Thorac Cardiovasc Surg; 2012 Feb; 143(2):326-31. PubMed ID: 21724204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcatheter aortic valve implantation for high risk patients with severe aortic stenosis using the Edwards Sapien balloon-expandable bioprosthesis: a single centre study with immediate and medium-term outcomes.
    Osten MD; Feindel C; Greutmann M; Chamberlain K; Meineri M; Rubin B; Mezody M; Ivanov J; Butany J; Horlick EM
    Catheter Cardiovasc Interv; 2010 Mar; 75(4):475-85. PubMed ID: 19937781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Six-month results of a repositionable and retrievable pericardial valve for transcatheter aortic valve replacement: the Direct Flow Medical aortic valve.
    Treede H; Tübler T; Reichenspurner H; Grube E; Pascotto A; Franzen O; Mueller R; Low R; Bolling SF; Meinertz T; Schofer J
    J Thorac Cardiovasc Surg; 2010 Oct; 140(4):897-903. PubMed ID: 20392455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: results of the Belgian national registry.
    Bosmans JM; Kefer J; De Bruyne B; Herijgers P; Dubois C; Legrand V; Verheye S; Rodrigus I;
    Interact Cardiovasc Thorac Surg; 2011 May; 12(5):762-7. PubMed ID: 21349890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transapical aortic valve implantation in patients with severely depressed left ventricular function.
    Unbehaun A; Pasic M; Buz S; Dreysse S; Kukucka M; Hetzer R; Drews T
    J Thorac Cardiovasc Surg; 2012 Jun; 143(6):1356-63. PubMed ID: 21840548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Worldwide experience with the 29-mm Edwards SAPIEN XT™ transcatheter heart valve in patients with large aortic annulus.
    Wendler O; Thielmann M; Schroefel H; Rastan A; Treede H; Wahlers T; Eichinger W; Walther T
    Eur J Cardiothorac Surg; 2013 Feb; 43(2):371-7. PubMed ID: 22522982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thirty-day outcome after transcatheter aortic valve implantation compared with surgical valve replacement in patients with high-risk aortic stenosis: a matched comparison.
    Stöhr R; Dohmen G; Herpertz R; Brehmer K; Aktug O; Koos R; Altiok E; Stegemann E; Autschbach R; Marx N; Hoffmann R
    Coron Artery Dis; 2011 Dec; 22(8):595-600. PubMed ID: 22009042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single center experience with transcatheter aortic valve implantation using the Edwards SAPIEN™ Valve.
    Nielsen HH; Thuesen L; Egeblad H; Poulsen SH; Klaaborg KE; Jakobsen CJ; Andersen HR; Hjortdal VE
    Scand Cardiovasc J; 2011 Oct; 45(5):261-6. PubMed ID: 21506661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and hemodynamic outcomes of "all-comers" undergoing transapical aortic valve implantation: results from the Italian Registry of Trans-Apical Aortic Valve Implantation (I-TA).
    D'Onofrio A; Rubino P; Fusari M; Salvador L; Musumeci F; Rinaldi M; Vitali EO; Glauber M; Di Bartolomeo R; Alfieri OR; Polesel E; Aiello M; Casabona R; Livi U; Grossi C; Cassese M; Pappalardo A; Gherli T; Stefanelli G; Faggian GG; Gerosa G
    J Thorac Cardiovasc Surg; 2011 Oct; 142(4):768-75. PubMed ID: 21840020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve.
    Thomas M; Schymik G; Walther T; Himbert D; Lefèvre T; Treede H; Eggebrecht H; Rubino P; Colombo A; Lange R; Schwarz RR; Wendler O
    Circulation; 2011 Jul; 124(4):425-33. PubMed ID: 21747054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early clinical outcome of aortic transcatheter valve-in-valve implantation in the Nordic countries.
    Ihlberg L; Nissen H; Nielsen NE; Rück A; Busund R; Klaarborg KE; Soendergaard L; Harnek J; Miettinen H; Eskola M; Wahba A; Laine M
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1047-54; discussion 1054. PubMed ID: 23998786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcatheter aortic valve implantation for severe aortic stenosis-a new paradigm for multidisciplinary intervention: a prospective cohort study.
    Dworakowski R; MacCarthy PA; Monaghan M; Redwood S; El-Gamel A; Young C; Bapat V; Hancock J; Wilson K; Brickham B; Wendler O; Thomas MR
    Am Heart J; 2010 Aug; 160(2):237-43. PubMed ID: 20691827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immediate and mid-term results of transfemoral aortic valve implantation using either the Edwards Sapien transcatheter heart valve or the Medtronic CoreValve System in high-risk patients with aortic stenosis.
    Attias D; Himbert D; Ducrocq G; Détaint D; Al-Attar N; Iung B; Francis F; Maury JM; Brochet E; Enguerrand D; Nataf P; Vahanian A
    Arch Cardiovasc Dis; 2010 Apr; 103(4):236-45. PubMed ID: 20656634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of transcatheter heart valves for a valve-in-valve implantation in patients with degenerated aortic bioprosthesis: technical considerations and results.
    Bapat V; Attia R; Redwood S; Hancock J; Wilson K; Young C; Thomas M
    J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1372-9; discussion 1379-80. PubMed ID: 23140962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transapical transcatheter aortic valve implantation: follow-up to 3 years.
    Ye J; Cheung A; Lichtenstein SV; Nietlispach F; Albugami S; Masson JB; Thompson CR; Munt B; Moss R; Carere RG; Jamieson WR; Webb JG
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1107-13, 1113.e1. PubMed ID: 20412948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early- and mid-term outcomes of transcatheter aortic valve implantation in patients with logistic EuroSCORE less than 20%: a comparative analysis between different risk strata.
    Tamburino C; Barbanti M; Capodanno D; Sarkar K; Cammalleri V; Scarabelli M; Mulè M; Immè S; Aruta P; Ussia GP
    Catheter Cardiovasc Interv; 2012 Jan; 79(1):132-40. PubMed ID: 21538786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is transapical aortic valve implantation really less invasive than minimally invasive aortic valve replacement?
    Zierer A; Wimmer-Greinecker G; Martens S; Moritz A; Doss M
    J Thorac Cardiovasc Surg; 2009 Nov; 138(5):1067-72. PubMed ID: 19740493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Permanent pacemaker implantation after transapical transcatheter aortic valve implantation.
    D'Ancona G; Pasic M; Unbehaun A; Hetzer R
    Interact Cardiovasc Thorac Surg; 2011 Oct; 13(4):373-6. PubMed ID: 21788300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of survival in 300 high-risk patients up to 2.5 years after transapical aortic valve implantation.
    Unbehaun A; Pasic M; Drews T; Dreysse S; Kukucka M; Hetzer R; Buz S
    Ann Thorac Surg; 2011 Oct; 92(4):1315-23. PubMed ID: 21958779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transapical aortic valve implantation in patients requiring redo surgery.
    Walther T; Falk V; Borger MA; Kempfert J; Ender J; Linke A; Schuler G; Mohr FW
    Eur J Cardiothorac Surg; 2009 Aug; 36(2):231-4; discussion 234-5. PubMed ID: 19324566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.